Skip to main content

Table 1 Experimental groups

From: Genetic and pharmacologic inhibition of Tpl2 kinase is protective in a mouse model of ventilator-induced lung injury

Strain treatment Sample (N)
WT Tpl2-/-
Control-PV curve and sample collection 10 10
Normal VT ventilation 8 8
High VT ventilation 8 8
High VT ventilation + Tpl2 inhibitor pretreatment 5  
High VT ventilation + Tpl2 inhibitor posttreatment 5  
Control-no ventilation (ERK1/2 phosphorylation) 6 6
Normal VT 60 min (ERK1/2 phosphorylation) 4 4
Normal VT 30 min + High VT 30 min (ERK1/2 phosphorylation) 8 8
Normal VT 30 min + High VT 30 min (ERK1/2 phosphorylation) + Tpl2 inhibitor pretreatment 4